Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Veraxa Biotech AG VRXA

Set alert

Price alert · VRXA

All alert types
1.03 USD -0.11 -9.65%

At close · Nov 2

1.08 +0.05 +4.85%

After hours · Nov 2, 4:39 PM ET

Bid
1.03 × 1
Ask
1.04 × 1
1.02 Day range 1.15
0.95 52-week range 27.36
YTD
-90.35%
1 year
-90.21%
Open
1.14
Prev close
1.14
Mkt cap
145.65M
Vol
286.81K
Avg vol
255.49K
EPS
-0.57
P/E
0.00
Div yield
0.00%
More statistics
Low
1.02
High
1.15

MAX chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The all-time price history for VRXA has not been loaded yet. Try again in a moment.

Revenue & Expenses

Income Tax Benefit → Expenses: $392.60KExpenses → Selling, General & Admin: $53.87MExpenses → Research & Development: $10.26MExpenses → Other Operating Expenses: $2.10MExpenses → Interest Expense: $3.55KExpenses → Other Expenses: $786.47KGross Profit → Expenses: $15.46KRevenue → Gross Profit: $15.46KRevenue → Cost of Revenue: $7.96KNet Loss → Expenses: $66.61MIncome Tax Benefit$392.60KGross Profit$15.46KNet Loss$66.61MCost of Revenue$7.96KExpenses$67.02MSelling, General & Admin$53.87MResearch & Development$10.26MOther Operating Expenses$2.10MInterest Expense$3.55KOther Expenses$786.47KRevenue$23.43K

Latest period ending Dec 31, 2025 · select a line to chart its full history

Income statement

Full income statement How to read it
VRXA annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024
23.43K0
15.46K0
-66.22M-28.92M
-66.61M-28.13M
-4.60-2.00

Balance sheet

Full balance sheet How to read it
VRXA annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024
1.61M5.36M
80.82M84.77M
96.59M53.71M
2.14M864.49K
-15.77M31.05M

Cash flow

Full cash flow How to read it
VRXA annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024
-9.90M-7.72M
-437.18K-120.88K
6.59M1.85M
-437.18K-120.88K
-3.75M-5.99M